0000899243-22-037000.txt : 20221125
0000899243-22-037000.hdr.sgml : 20221125
20221125130518
ACCESSION NUMBER: 0000899243-22-037000
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221122
FILED AS OF DATE: 20221125
DATE AS OF CHANGE: 20221125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laponis Adam
CENTRAL INDEX KEY: 0001827198
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39616
FILM NUMBER: 221419415
MAIL ADDRESS:
STREET 1: C/O EARGO, INC.
STREET 2: 2665 NORTH FIRST STREET, SUITE 300
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eargo, Inc.
CENTRAL INDEX KEY: 0001719395
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 273879804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2665 NORTH FIRST STREET
STREET 2: SUITE 300
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 650-351-7700
MAIL ADDRESS:
STREET 1: 2665 NORTH FIRST STREET
STREET 2: SUITE 300
CITY: SAN JOSE
STATE: CA
ZIP: 95134
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-22
0
0001719395
Eargo, Inc.
EAR
0001827198
Laponis Adam
C/O EARGO, INC.
2665 NORTH FIRST STREET, SUITE 300
SAN JOSE
CA
95134
0
1
0
0
Chief Financial Officer
Common Stock
2022-11-22
4
X
0
4995
0.50
A
64222
D
Subscription Rights (right to buy)
0.50
2022-11-22
4
X
0
525
0.00
A
2022-10-31
Common Stock
4995
0
D
Represents shares of the Issuer's Common Stock acquired by the Reporting Person following the exercise of his basic subscription rights in connection with the Issuer's rights offering to holders of Common Stock, as described in the issuer's prospectus dated October 27, 2022 (the "Rights Offering"). Each holder of Common Stock of record as of October 24, 2022 received one right for each share of Common Stock, and each right entitled the holder of Common Stock to purchase 9.5151 shares of Common Stock at the subscription price of $0.50 per whole share.
Represents exercise price per whole share of Common Stock.
The Rights Offering expired on November 17, 2022, and final determination of the pro rata allocation for each exercising holder was determined on November 22, 2022.
/s/ Christy La Pierre, Attorney-in-Fact for Adam Laponis
2022-11-25